A brief treatment for veterans with PTSD: an open-label case-series study

被引:0
作者
Kindt, Merel [1 ]
Soeter, Marieke [2 ]
机构
[1] Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands
[2] Netherlands Org Appl Sci Res TNO, Work Hlth & Technol, Leiden, Netherlands
来源
FRONTIERS IN PSYCHIATRY | 2023年 / 14卷
关键词
reconsolidation; imagery rescripting; trauma memory; treatment; veterans; PTSD; POSTTRAUMATIC-STRESS-DISORDER; RECONSOLIDATION INTERVENTION; EMOTIONAL MEMORY; IMAGERY; FEAR; METAANALYSIS; PROPRANOLOL; EXTINCTION; EXPOSURE; EFFICACY;
D O I
10.3389/fpsyt.2023.1260175
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
IntroductionDespite the positive outcomes observed in numerous individuals undergoing trauma-focused psychotherapy for PTSD, veterans with this condition experience notably diminished advantages from such therapeutic interventions in comparison to non-military populations.MethodsIn a preliminary study we investigated the efficacy of an innovative treatment approach in a small sample of veterans (n = 7). Recognizing that accessing and targeting trauma memory in veterans with PTSD may be more challenging compared to other patient populations, we employed unique and personalized retrieval cues that engaged multiple senses and were connected to the context of their trauma. This was followed by a session focused on memory reconsolidation, which incorporated both psychological techniques (i.e., imagery rescripting) and a pharmacological component (i.e., 40 mg of propranolol).ResultsThe findings from this small-scale case series cautiously indicate that this brief intervention, typically consisting of only one or two treatment sessions, shows promise in producing significant effects on symptoms of PTSD, distress and quality of life.This is particularly noteworthy given the complex symptomatology experienced by the veterans in this study.ConclusionTo summarize, there are grounds for optimism regarding this brief treatment of combat-related PTSD. It appears that the potential for positive outcomes is far greater than commonly believed, as demonstrated by the encouraging results of this pilot study.
引用
收藏
页数:10
相关论文
共 50 条
  • [11] Oral zinc sulfate treatment for viral warts: An open-label study
    Mun, Je-Ho
    Kim, Su-Han
    Jung, Do-Sang
    Ko, Hyun-Chang
    Kim, Byung-Soo
    Kwon, Kyung-Sool
    Kim, Moon-Bum
    JOURNAL OF DERMATOLOGY, 2011, 38 (06) : 541 - 545
  • [12] Pregabalin in the Treatment of Chronic Migraine: An Open-Label Study
    Calandre, Elena P.
    Garcia-Leiva, Juan M.
    Rico-Villademoros, Fernando
    Vilchez, Juan S.
    Rodriguez-Lopez, Carmen M.
    CLINICAL NEUROPHARMACOLOGY, 2010, 33 (01) : 35 - 39
  • [13] Topiramate in the treatment of trichotillomania: an open-label pilot study
    Lochner, Christine
    Seedat, Soraya
    Niehaus, Dana J. H.
    Stein, Dan J.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (05) : 255 - 259
  • [14] Prolonged Exposure Therapy for Experiential Avoidance: A Case-Series Study
    Ghafoori, Bita
    CLINICAL CASE STUDIES, 2018, 17 (03) : 123 - 135
  • [15] Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD
    Davis, Alan K.
    Levin, Adam W.
    Nagib, Paul B.
    Armstrong, Stacey B.
    Lancelotta, Rafaelle L.
    BMJ OPEN, 2023, 13 (05):
  • [16] Effects of intranasal (S)-ketamine on Veterans with co-morbid treatment-resistant depression and PTSD: A retrospective case series
    Artin, Hewa
    Bentley, Sean
    Mehaffey, Eamonn
    Liu, Fred X.
    Sojourner, Kevin
    Bismark, Andrew W.
    Printz, David
    Lee, Ellen E.
    Martis, Brian
    De Peralta, Sharon
    Baker, Dewleen G.
    Mishra, Jyoti
    Ramanathan, Dhakshin
    ECLINICALMEDICINE, 2022, 48
  • [17] Intravenous arketamine for treatment-resistant depression: open-label pilot study
    Leal, Gustavo C.
    Bandeira, Igor D.
    Correia-Melo, Fernanda S.
    Telles, Manuela
    Mello, Rodrigo P.
    Vieira, Flavia
    Lima, Cassio S.
    Jesus-Nunes, Ana Paula
    Guerreiro-Costa, Livia N. F.
    Marback, Roberta F.
    Caliman-Fontes, Ana Teresa
    Marques, Breno L. S.
    Bezerra, Marilia L. O.
    Dias-Neto, Alberto L.
    Silva, Samantha S.
    Sampaio, Aline S.
    Sanacora, Gerard
    Turecki, Gustavo
    Loo, Colleen
    Lacerda, Acioly L. T.
    Quarantini, Lucas C.
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2021, 271 (03) : 577 - 582
  • [18] Examining the effectiveness of an intensive, 2-week treatment program for military personnel and veterans with PTSD: Results of a pilot, open-label, prospective cohort trial
    Bryan, Craig J.
    Leifker, Feea R.
    Rozek, David C.
    Bryan, AnnaBelle O.
    Reynolds, Mira L.
    Oakey, D. Nicolas
    Roberge, Erika
    JOURNAL OF CLINICAL PSYCHOLOGY, 2018, 74 (12) : 2070 - 2081
  • [19] Open-Label Support for Duloxetine for the Treatment of Panic Disorder
    Simon, Naomi M.
    Kaufman, Rebecca E.
    Hoge, Elizabeth A.
    Worthington, John J.
    Herlands, Nannette N.
    Owens, Maryann E.
    Pollack, Mark H.
    CNS NEUROSCIENCE & THERAPEUTICS, 2009, 15 (01) : 19 - 23
  • [20] Behavioral Activation for Orthopedic Trauma Patients After Discharge: A Case Series Report of an Open-Label, Prospective Observational Pilot Study
    Ching, Terence H. W.
    Gitajn, Ida L.
    Rotenberg, Sivan
    Lyons, Kathleen D.
    Brady, Robert E.
    COGNITIVE AND BEHAVIORAL PRACTICE, 2023, 30 (04) : 597 - 609